a developer of next generation products based on the transformative potential of gene therapy
Industry Biotechnology
A.I.dvisor indicates that over the last year, BLUE has been loosely correlated with BEAM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BLUE jumps, then BEAM could also see price increases.
Ticker / NAME | Correlation To BLUE | 1D Price Change % | ||
---|---|---|---|---|
BLUE | 100% | -3.64% | ||
BEAM - BLUE | 43% Loosely correlated | -4.33% | ||
NTLA - BLUE | 42% Loosely correlated | -6.15% | ||
ARGX - BLUE | 42% Loosely correlated | -0.72% | ||
EDIT - BLUE | 41% Loosely correlated | -6.42% | ||
CRSP - BLUE | 41% Loosely correlated | -5.90% | ||
More |
Ticker / NAME | Correlation To BLUE | 1D Price Change % |
---|---|---|
BLUE | 100% | -3.64% |
transformative theme (4 stocks) | 26% Poorly correlated | -7.14% |
gene therapy theme (12 stocks) | 22% Poorly correlated | -4.25% |
biotechnology theme (238 stocks) | 20% Poorly correlated | -1.76% |